Treponema pallidum outer membrane proteins: current status and prospects.


Journal

Pathogens and disease
ISSN: 2049-632X
Titre abrégé: Pathog Dis
Pays: United States
ID NLM: 101595366

Informations de publication

Date de publication:
27 09 2022
Historique:
received: 30 01 2022
revised: 30 05 2022
accepted: 20 07 2022
pubmed: 24 7 2022
medline: 30 9 2022
entrez: 23 7 2022
Statut: ppublish

Résumé

The outer membrane proteins (OMPs) of Treponema pallidum subsp. pallidum (T. pallidum), the etiological agent of the sexually transmitted disease syphilis, have long been a hot research topic. Despite many hurdles to studying the pathogen, especially the inability to manipulate T. pallidum in vitro genetically, considerable progress has been made in elucidating the structure, pathogenesis and functions of T. pallidum OMPs. In this review, we integrate this information to garner fresh insights into the role of OMPs in the diagnosis, pathogenicity and vaccine development of T. pallidum. Collectively, the essential scientific discussions herein should provide a framework for understanding the current status and prospects of T. pallidum OMPs.

Identifiants

pubmed: 35869970
pii: 6649208
doi: 10.1093/femspd/ftac023
pii:
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Auteurs

Jinlin Chen (J)

Department of Clinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang 421001, China.

Jielite Huang (J)

Department of Clinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang 421001, China.

Zhuoran Liu (Z)

Department of Clinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang 421001, China.

Yafeng Xie (Y)

Department of Clinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang 421001, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH